SCHEMBL6674528

SCHEMBL6674528

COC(=O)N[C@@H]1Cc2ccc(NC(=O)Oc3cccc(C)c3-c3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MTTP P55157 16/20 0.77
APOB P04114 15/20 0.77
SMO Q99835 7/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6678706 1.00 MTTP (0.77) MTTPAPOBSMO
SCHEMBL6673949 0.91 MTTP (0.63) MTTPAPOBSMO
SCHEMBL4785948 0.87 MTTP (1.00) MTTPAPOBSMO
SCHEMBL7038523 0.87 MTTP (1.00) MTTPAPOBSMO
SCHEMBL10205353 0.87 MTTP (1.00) MTTPAPOBSMO
SCHEMBL6196022 0.80 MTTP (0.87) MTTPAPOBSMO
SCHEMBL13591624 0.79 MTTP (0.85) MTTPAPOBSMO
SCHEMBL5961560 0.78 SMO (0.85) MTTPAPOBSMO
SCHEMBL13591625 0.77 APOB (0.73) MTTPAPOBSMO
SCHEMBL7764346 0.76 APOB (1.00) MTTPAPOBSMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP claimed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO claimed
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed